Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain

Status

UNKNOWN

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03016364

Enrollment

200

Registered

2017-01-10

Start date

2017-01-31

Completion date

2019-12-31

Last updated

2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxycodone, Pain, Physicians

Brief summary

The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.

Interventions

DEVICEAPP software

A software used to by physicians to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* a histologically confirmed diagnosis of Cancer or Sarcoma * advanced patients with severe cancer pain(score \>3) * having used or expected to use the Oxycodone Hydrochloride Prolonged-release Tablets

Exclusion criteria

* allergic to Oxycodone Hydrochloride Prolonged-release Tablets, or other reasons (determined by clinical doctors) unable to use the Opioids

Design outcomes

Primary

Measure	Time frame
Numerical Pain Rating Scale	upto 8 months

Countries

China

Contacts

Primary ContactPeng Liu, MD

13910216310@163.com8610-87788405

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026